Literature DB >> 6369957

Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes.

O E Michaelis, K C Ellwood, J M Judge, N W Schoene, C T Hansen.   

Abstract

A new congenic strain of genetically obese rat, SHR/N-corpulent (cp), was studied. Young male corpulent (cp/cp) and lean (cp/+ or +/+) rats approximately 5 wk of age were fed a diet containing 54% carbohydrate as either sucrose or cooked cornstarch for 9 wk. A phenotype effect was observed with body weight, fasting levels of serum insulin, triglyceride and total cholesterol, levels of serum insulin and glucose after an oral glucose load, and level of urine glucose (corpulent greater than lean), and with systolic blood pressure (corpulent less than lean). Only lean rats were hypertensive. Corpulent rats were hyperinsulinemic, hyperlipidemic, exhibited glycosuria, and were hyperglycemic after an oral glucose load. Lean rats were hyperinsulinemic, but normoglycemic. A diet effect (sucrose greater than starch) was observed with body weight, level of serum glucose after an oral glucose load, and urine volume in both corpulent and lean rats, and with levels of serum insulin and total urine glucose in corpulent rats. Corpulent rats fed sucrose had 20 to 40% higher levels of serum glucose and insulin after an oral glucose load, and twice the amount of total urine glucose, than did corpulent rats fed starch. The data demonstrate that corpulent rats have metabolic characteristics associated with insulin-independent diabetes in humans and that sucrose is more diabetogenic than starch. Manifestation of hyperglycemia in this model may be the result of superimposing obesity on an insulin-resistant genetic background.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369957     DOI: 10.1093/ajcn/39.4.612

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

Review 1.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

2.  Refeeding hypertension in dietary obesity.

Authors:  P Ernsberger; D O Nelson
Journal:  Am J Physiol       Date:  1988-01

3.  Insulin-independent diabetes mellitus (type II). Spontaneous hypertensive/NIH-corpulent rat.

Authors:  O E Michaelis; D H Patrick; C T Hansen; J J Canary; R M Werner; N Carswell
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

4.  Preventive effects of the extract of kinka-cha, a folk tea, on a rat model of metabolic syndrome.

Authors:  Hisae Oku; Yuko Ogawa; Emiko Iwaoka; Yu Yamaguchi; Satomi Kagota; Shinozuka Kazumasa; Masaru Kunitomo; Kyoko Ishiguro
Journal:  J Nat Med       Date:  2011-04-10       Impact factor: 2.343

5.  Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.

Authors:  Shizuyo Tanaka; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Daisuke Kobayashi; Naomi Kudo; Yoichi Kawashima
Journal:  Lipids       Date:  2013-09-18       Impact factor: 1.880

Review 6.  Cardiovascular disease in the JCR:LA-cp rat.

Authors:  J C Russell; S E Graham; M Richardson
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Diabetic glomerulopathy in the SHR/N-corpulent rat: role of dietary carbohydrate in a model of NIDDM.

Authors:  M T Velasquez; A A Abraham; P L Kimmel; T Farkas-Szallasi; O E Michaelis
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

8.  Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model.

Authors:  Michio Hashimoto; Masanori Katakura; Toru Nabika; Yoko Tanabe; Shahdat Hossain; Satoru Tsuchikura; Osamu Shido
Journal:  Med Gas Res       Date:  2011-11-03

9.  Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.

Authors:  Christine G Schnackenberg; Melissa H Costell; Daniel J Krosky; Jianqi Cui; Charlene W Wu; Victor S Hong; Mark R Harpel; Robert N Willette; Tian-Li Yue
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

Review 10.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.